In Russia, the VII National Congress of Physicians, one of the main themes of which was the rapid spread of non-alcoholic fatty liver disease in the country's citizens. Statistics increased incidence, mechanism of development of this disease and how to treat it were discussed at a symposium on "The role of essential phospholipids in the treatment of liver diseases. The present and the future. "
MD, Ph.D., Professor, Department of Propedeutics of Internal Medicine and Gastroenterology therapeutic faculty of Moscow State University of Medicine and Dentistry Tatiana Polunin said that in the ranking of the most common liver disease NAFLD It occupies the second position (12%), giving the lead to hepatitis C (32%). Nonalcoholic fatty disease is diagnosed in 27% of the inhabitants of our country (ie around 40 million Russians).
This disease is caused by a metabolic disorder. It may develop on the background of abdominal obesity, diabetes, hypertension and disorders of lipid metabolism. "Guess" NAFLD You can at the waist - in patients with men, it is more than 102 cm for women - more than 88 cm.
This initial stage of NAFLD (fatty degeneration caused by violation metabolizmaa fatty acids in the liver cells) are almost always asymptomatic. Over time, the disease moves to a new level - the internal organ is inflamed. This condition doctors call stetogepatitom. It is characterized by scarring of the liver, which in some cases develops into cirrhosis. Cirrhosis is a deadly disease, because causing portal hypertension or hepatic cancer. Progression of the disease is quite fast - now 27% of the Russian population, who suffer from NAFLD, from 12% to 18% are stage stetogepatita.
For effective treatment of the patient's disease is an urgent need to lose weight and adjust insulin resistance and lipid metabolism. At the stage of steatohepatitis is necessary to remove inflammation (to prevent further fibrosis and remove oxidative stress).
Industry News
Go back to the main page
No comments:
Post a Comment